Greater Cannabis Company (GCAN) Accumulated Expenses (2016 - 2026)

Greater Cannabis Company's Accumulated Expenses history runs 11 years deep, the most recent figure standing at $500350.0 for Q1 2026.

• In Q1 2026, Accumulated Expenses rose 521.97% year-over-year to $500350.0; the TTM figure through Mar 2026 stood at $500350.0 (up 521.97% YoY), while the FY2025 annual figure was $470350.0, up 23.66% from the prior year.
• Accumulated Expenses was $500350.0 for Q1 2026 at Greater Cannabis Company, up from $470350.0 in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $500350.0 in Q1 2026 to a low of $25112.0 in Q1 2022.
• Historically, Accumulated Expenses has averaged $269532.3 across 5 years, with a median of $316675.0 in 2023.
• The sharpest annual moves came in 2022 and 2025: Accumulated Expenses jumped 2985.01% in 2022, then slumped 76.36% in 2025.
• A 5-year view of Accumulated Expenses shows it stood at $263000.0 in 2022, then advanced by 29.41% to $340350.0 in 2023, then rose by 11.75% to $380350.0 in 2024, then advanced by 23.66% to $470350.0 in 2025, then rose by 6.38% to $500350.0 in 2026.
• The last three Accumulated Expenses figures came in at $500350.0 (Q1 2026), $470350.0 (Q4 2025), and $460350.0 (Q3 2025), per Business Quant data.